You searched for "Ocular surface"

27 results found

Significant improvements in Ocular Surface Disease (OSD) in Glaucoma patients reported following implantation of iStent inject at the time of cataract surgery

A prospective study of patients undergoing trabecular micro-bypass implantation with iStent or iStent inject® at the time of cataract surgery shows clinically and statistically significant improvements in ocular surface disease (OSD), including tear break-up time, corneal/conjunctival staining, and Ocular Surface Disease Index scores (OSDI).

Thea Academy Webinar Series 2023: How Preservative-Free glaucoma treatments improve ocular surface disease and quality of life for patients.

All webinars will be live and interactive at 7.30pm to 8.30pm. 1 Interactive CPD Point is available for all webinars and is applied for via the GOC and RCO. Confirmed Speaker: Mr Simon Dulku, MA, Pathology, MBBS, FRCOphth, MRCOphth

More than six million treatments with AMARIS

The SCHWIND AMARIS product family proves to be a constant model for success in corneal surgery and continues to be in high demand worldwide. Around 1,200 AMARIS eximer lasers have been installed in 100 countries so far. Whether in Africa, Asia, Australia and Oceania, Europe, North or South America: SCHWIND users have...
  • 1
  • 2
  • 3 (current)